Barosense (Redwood City, CA) a clinical-stage medical device company focused on minimally invasive trans-oral endoscopic restrictive implant system to treat obesity, closed a $27M Series D financing. Participants include Pappas Ventures, Delphi Ventures, Frazier Healthcare Ventures, Invesco Private Capital, RWI Ventures, Synergy Life Science Partners and Wharton Ventures.